MarketPeel
Insider Trading Intelligence
Pricing
…
RS

Romesh Subramanian

DYN
CHIEF SCIENTIFIC OFFICER · DYNE THERAPEUTICS, INC. · CIK 0001824655
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Sep 2020
HOLDINGS NOW
566,249
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Romesh Subramanian. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
DYN · 566,249 shares · as of Sep 17, 2020
0141,562283,125424,687566,249SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
DYN
DYNE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
41,309——566,249Sep 17, 2020Sep 18, 2020 ↗
DYN
DYNE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
128,185——128,185Sep 16, 2020Sep 18, 2020 ↗
Other insiders · DYN
Loading peer insiders…
About this filer
CIK 0001824655
ROLE
Chief Scientific Officer
PRIMARY
DYN
COMPANIES
1
ACTIVE SINCE
Sep 2020
MARKETPEEL · /INSIDER/0001824655DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback